UBS Group’s Hanwha Q CELLS Co., Ltd. HQCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-301
| Closed | -$3K | – | 8594 |
|
|
2018
Q4 | $3K | Sell |
301
-1,100
| -79% | -$10.4K | ﹤0.01% | 7771 |
|
|
2018
Q3 | $12K | Buy |
1,401
+1,015
| +263% | +$7.63K | ﹤0.01% | 7096 |
|
|
2018
Q2 | $2K | Sell |
386
-844
| -69% | -$5.91K | ﹤0.01% | 7781 |
|
|
2018
Q1 | $9K | Sell |
1,230
-2,134
| -63% | -$16.4K | ﹤0.01% | 6974 |
|
|
2017
Q4 | $24K | Buy |
+3,364
| New | +$26.3K | ﹤0.01% | 6428 |
|
|
2017
Q3 | – | Sell |
-254
| Closed | -$2K | – | 8207 |
|
|
2017
Q2 | $2K | Sell |
254
-1,173
| -82% | -$8.07K | ﹤0.01% | 7435 |
|
|
2017
Q1 | $10K | Buy |
1,427
+874
| +158% | +$7.06K | ﹤0.01% | 6642 |
|
|
2016
Q4 | $5K | Buy |
553
+534
| +2,811% | +$5.25K | ﹤0.01% | 7278 |
|
|
2016
Q3 | $0 | Sell |
19
-355
| -95% | -$4.56K | ﹤0.01% | 8133 |
|
|
2016
Q2 | $5K | Buy |
374
+155
| +71% | +$2.01K | ﹤0.01% | 7167 |
|
|
2016
Q1 | $3K | Sell |
219
-1,432
| -87% | -$24.2K | ﹤0.01% | 7245 |
|
|
2015
Q4 | $36K | Buy |
1,651
+1,296
| +365% | +$24.7K | ﹤0.01% | 6159 |
|
|
2015
Q3 | $5K | Buy |
355
+95
| +37% | +$1.19K | ﹤0.01% | 7756 |
|
|
2015
Q2 | $5K | Sell |
260
-1,155
| -82% | -$23.3K | ﹤0.01% | 7908 |
|
|
2015
Q1 | $29K | Sell |
1,415
-2,378
| -63% | -$28.5K | ﹤0.01% | 6602 |
|
|
2014
Q4 | $42K | Buy |
+3,793
| New | +$66.8K | ﹤0.01% | 6712 |
|
UBS Group's HQCL Position: Q1 2019 in Review
UBS Group sold out of Hanwha Q CELLS Co., Ltd. (HQCL) in Q1 2019, closing a stake of 301 shares — an estimated $3K sold.
UBS Group first reported a position in HQCL in Q4 2014 and held it in 16 quarters. The position peaked at $42K in Q4 2014. 0 funds tracked by Wall St. Rank hold HQCL as of Q1 2019.
- UBS Group reported no remaining Hanwha Q CELLS Co., Ltd. position as of Q1 2019 after selling out during the quarter.
- UBS Group sold 301 Hanwha Q CELLS Co., Ltd. shares in Q1 2019, an estimated $3K.
- UBS Group first reported a position in Hanwha Q CELLS Co., Ltd. in Q4 2014 and held it in 16 quarters.
- UBS Group's Hanwha Q CELLS Co., Ltd. position peaked at $42K in Q4 2014.
- 0 funds tracked by Wall St. Rank held Hanwha Q CELLS Co., Ltd. as of Q1 2019.
Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.